Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Warwick | OTHER |
| Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University | OTHER |
Not provided
Not provided
Not provided
Not provided
Innovative strategies are required to manage COVID-19 in the communities. Back to Roots community based project was a collaborative, pilot intervention program in British Asian community to assess the efficacy and safety of Ayurveda intervention in relieving symptoms of mild-to-moderate COVID-19.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Ayurveda Intervention | Experimental | Ashwagandha, Giloy and Tulsi were given in tablet form for oral administration. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ayurveda | Other | Dosage was used in common range (Ashwagandha: Doses range from 250 mg to 5 g; Giloy: range from 500mg to 1g; Tulsi: 500mg-1g) Dosage were altered based on age, weight and severity of symptoms. |
| Measure | Description | Time Frame |
|---|---|---|
| Time to clinical recovery | To evaluate the therapeutic efficacy, mean days for clinical recovery were recorded from AiM Covid Application | Up to 14-days |
| Proportion of patient with negative conversion in nasopharyngeal swab | To evaluate the therapeutic efficacy, promotion of patients were recorded through AiM Covid application | Up to 14 days |
| Measure | Description | Time Frame |
|---|---|---|
| Clinical Outcome | Clinical Outcome was recorded on 7-pont ordinal scale of COVID-19 | Up to 14-days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Neha Sharma | Aarogyam UK | Study Director |
| Dipa Modi | East Park Medical Centre, NHS trust, Leicester | Study Chair |
| Vishwesh Kulkarni | University of Warwick | Principal Investigator |
| Abhimanyu Kumar | Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aarogyam UK | Leicester | Leicestershire | United Kingdom |
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
| ID | Term |
|---|---|
| D008515 | Medicine, Ayurvedic |
| ID | Term |
|---|---|
| D008519 | Medicine, Traditional |
| D000529 | Complementary Therapies |
| D013812 | Therapeutics |
Not provided
Not provided
Community Based Participatory Research
Not provided
Not provided
Not provided
Not provided
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |